Advertisement

Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals

  • D. Gravel
    Correspondence
    Corresponding author. Address: Nosocomial and Occupational Infections Section, Public Health Agency of Canada, 100 Eglantine Driveway, PL 0601E2, Ottawa, Ontario, K1A 0L2, Canada. Tel.: +1 613 954 2853; fax: +1 613 946 0678.
    Affiliations
    Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Canada
    Search for articles by this author
  • G. Taylor
    Affiliations
    University of Alberta Hospital, Edmonton, Alberta, Canada
    Search for articles by this author
  • M. Ofner
    Affiliations
    Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Canada
    Search for articles by this author
  • L. Johnston
    Affiliations
    QEII Health Sciences Centre, Halifax, Nova Scotia, Canada
    Search for articles by this author
  • M. Loeb
    Affiliations
    Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
    Search for articles by this author
  • V.R. Roth
    Affiliations
    The Ottawa Hospital, Ottawa, Ontario, Canada
    Search for articles by this author
  • J. Stegenga
    Affiliations
    Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Canada
    Search for articles by this author
  • E. Bryce
    Affiliations
    Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
    Search for articles by this author
  • Author Footnotes
    1 Members of the Canadian Nosocomial Infection Surveillance Program who participated in the Point Prevalence Survey for Healthcare-Acquired Infections: Dr Elizabeth Bryce, Vancouver General Hospital, Vancouver, BC; Dr Gordon Dow, The Moncton Hospital, Moncton, NB; Dr John Embil, Health Sciences Centre, Winnipeg, Manitoba; Dr Joanne Embree, Health Sciences Centre, Winnipeg, Manitoba; Dr Michael Gardam, University Health Network, Toronto, Ontario; Denise Gravel, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Elizabeth Henderson, Peter Lougheed Centre, Calgary, Alberta; Dr James Hutchinson, Health Sciences Centre, St John's, Newfoundland; Dr Michael John, London Health Sciences Centre, London, Ontario; Dr Lynn Johnston, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr Pamela Kibsey, Victoria General Hospital, Victoria, BC; Dr Joanne Langley, IWK Health Science Centre, Halifax, NS; Dr Mark Loeb, Hamilton Health Sciences Corporation and St Joseph's Healthcare, Hamilton, Ontario; Dr Anne Matlow, Hospital for Sick Children, Toronto, Ontario; Dr Allison McGeer, Mount Sinai Hospital, Toronto, Ontario; Dr Sophie Michaud, CHUS-Hôpital Fleurimont, Sherbrooke, Quebec; Dr Mark Miller, SMBD–Jewish General Hospital, Montreal, Quebec; Dr Dorothy Moore, Montreal Children's Hospital, Montreal, Quebec; Dr Michael Mulvey, National Microbiology Laboratory, Public Health Agency of Canada; Marianna Ofner, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Ms Shirley Paton, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Virginia Roth, The Ottawa Hospital, Ottawa, Ontario; Jacob Stegenga, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Geoffrey Taylor, University of Alberta Hospital, Edmonton, Alberta; Dr Karl Weiss, Maisonneuve–Rosemont Hospital, Montreal, Quebec; Dr Alice Wong, Royal University Hospital, Saskatoon, Saskatchewan; Dr Dick Zoutman, Kingston General Hospital, Kingston, Ontario.
    the Canadian Nosocomial Infection Surveillance Program
    Footnotes
    1 Members of the Canadian Nosocomial Infection Surveillance Program who participated in the Point Prevalence Survey for Healthcare-Acquired Infections: Dr Elizabeth Bryce, Vancouver General Hospital, Vancouver, BC; Dr Gordon Dow, The Moncton Hospital, Moncton, NB; Dr John Embil, Health Sciences Centre, Winnipeg, Manitoba; Dr Joanne Embree, Health Sciences Centre, Winnipeg, Manitoba; Dr Michael Gardam, University Health Network, Toronto, Ontario; Denise Gravel, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Elizabeth Henderson, Peter Lougheed Centre, Calgary, Alberta; Dr James Hutchinson, Health Sciences Centre, St John's, Newfoundland; Dr Michael John, London Health Sciences Centre, London, Ontario; Dr Lynn Johnston, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr Pamela Kibsey, Victoria General Hospital, Victoria, BC; Dr Joanne Langley, IWK Health Science Centre, Halifax, NS; Dr Mark Loeb, Hamilton Health Sciences Corporation and St Joseph's Healthcare, Hamilton, Ontario; Dr Anne Matlow, Hospital for Sick Children, Toronto, Ontario; Dr Allison McGeer, Mount Sinai Hospital, Toronto, Ontario; Dr Sophie Michaud, CHUS-Hôpital Fleurimont, Sherbrooke, Quebec; Dr Mark Miller, SMBD–Jewish General Hospital, Montreal, Quebec; Dr Dorothy Moore, Montreal Children's Hospital, Montreal, Quebec; Dr Michael Mulvey, National Microbiology Laboratory, Public Health Agency of Canada; Marianna Ofner, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Ms Shirley Paton, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Virginia Roth, The Ottawa Hospital, Ottawa, Ontario; Jacob Stegenga, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Geoffrey Taylor, University of Alberta Hospital, Edmonton, Alberta; Dr Karl Weiss, Maisonneuve–Rosemont Hospital, Montreal, Quebec; Dr Alice Wong, Royal University Hospital, Saskatoon, Saskatchewan; Dr Dick Zoutman, Kingston General Hospital, Kingston, Ontario.
    Affiliations
    Vancouver General Hospital, Vancouver, BC, Canada
    Search for articles by this author
  • Anne Matlow
    Affiliations
    Vancouver General Hospital, Vancouver, BC, Canada

    Hospital for Sick Children, Toronto, Ontario, Canada
    Search for articles by this author
  • Author Footnotes
    1 Members of the Canadian Nosocomial Infection Surveillance Program who participated in the Point Prevalence Survey for Healthcare-Acquired Infections: Dr Elizabeth Bryce, Vancouver General Hospital, Vancouver, BC; Dr Gordon Dow, The Moncton Hospital, Moncton, NB; Dr John Embil, Health Sciences Centre, Winnipeg, Manitoba; Dr Joanne Embree, Health Sciences Centre, Winnipeg, Manitoba; Dr Michael Gardam, University Health Network, Toronto, Ontario; Denise Gravel, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Elizabeth Henderson, Peter Lougheed Centre, Calgary, Alberta; Dr James Hutchinson, Health Sciences Centre, St John's, Newfoundland; Dr Michael John, London Health Sciences Centre, London, Ontario; Dr Lynn Johnston, Queen Elizabeth II Health Sciences Centre, Halifax, NS; Dr Pamela Kibsey, Victoria General Hospital, Victoria, BC; Dr Joanne Langley, IWK Health Science Centre, Halifax, NS; Dr Mark Loeb, Hamilton Health Sciences Corporation and St Joseph's Healthcare, Hamilton, Ontario; Dr Anne Matlow, Hospital for Sick Children, Toronto, Ontario; Dr Allison McGeer, Mount Sinai Hospital, Toronto, Ontario; Dr Sophie Michaud, CHUS-Hôpital Fleurimont, Sherbrooke, Quebec; Dr Mark Miller, SMBD–Jewish General Hospital, Montreal, Quebec; Dr Dorothy Moore, Montreal Children's Hospital, Montreal, Quebec; Dr Michael Mulvey, National Microbiology Laboratory, Public Health Agency of Canada; Marianna Ofner, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Ms Shirley Paton, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Virginia Roth, The Ottawa Hospital, Ottawa, Ontario; Jacob Stegenga, Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada; Dr Geoffrey Taylor, University of Alberta Hospital, Edmonton, Alberta; Dr Karl Weiss, Maisonneuve–Rosemont Hospital, Montreal, Quebec; Dr Alice Wong, Royal University Hospital, Saskatoon, Saskatchewan; Dr Dick Zoutman, Kingston General Hospital, Kingston, Ontario.

      Summary

      A survey of adult patients 19 years of age and older was conducted in February 2002 in hospitals across Canada to estimate the prevalence of healthcare-associated infections (HAIs). A total of 5750 adults were surveyed; 601 of these had 667 HAIs, giving a prevalence of 10.5% infected patients and 11.6% HAIs. Urinary tract infections (UTI) were the most frequent HAI, shown by 194 (3.4%) of the patients surveyed. Pneumonia was found in 175 (3.0%) of the patients, surgical site infections (SSI) in 146 (2.5%), bloodstream infections (BSI) in 93 (1.6%) and Clostridium difficile-associated diarrhoea (CDAD) in 59 (1%). In this first national point prevalence study in Canada, the prevalence of HAI was found to be similar to that reported by other industrialized countries.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hospital Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Haley R.W.
        • Culver D.H.
        • White J.W.
        • et al.
        The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals.
        Am J Epidemiol. 1985; 121: 182-205
        • French G.L.
        • Cheng A.F.B.
        • Wong S.L.
        • Donnan S.
        Repeated prevalence surveys for monitoring effectiveness of hospital infection control.
        Lancet. 1989; 28: 1021-1023
        • Weinstein J.W.
        • Mazon D.
        • Pantelick E.
        • Reagan-Cirincione P.
        • Dembry L.M.
        • Hierholzer W.J.
        A decade of prevalence surveys in a tertiary-care center: trends in nosocomial infection rates, device utilization, and patient acuity.
        Infect Control Hosp Epidemiol. 1999; 20: 543-548
        • Gikas A.
        • Pediaditis I.
        • Roumbelaki M.
        • et al.
        Repeated multi-centre prevalence surveys of hospital-acquired infection in Greek hospital.
        J Hosp Infect. 1999; 41: 11-18
        • Sax G.
        • Hugonnet S.
        • Harbarth S.
        • Herrault P.
        • Pittet D.
        Variation in nosocomial infection prevalence according to patient care settings: a hospital wide survey.
        J Hosp Infect. 2001; 48: 27-32
        • Freeman J.
        • Rosner B.A.
        • McGowan J.E.
        Adverse effects of nosocomial infection.
        J Infect Dis. 1979; 140: 732-740
        • French G.L.
        • Cheng A.F.B.
        Measurement of the costs of hospital infection by prevalence surveys.
        J Hosp Infect. 1991; 18: 65-72
        • Harbarth S.
        • Ruef C.
        • Francoli P.
        • Widmer A.
        • Pittet D.
        Nosocomial infections in Swiss university hospitals: a multi-centre survey and review of the published experience.
        Schweiz Med Wochenschr. 1999; 129: 1521-1528
        • Sramova H.
        • Bartonova A.
        • Bolek S.
        • Krecmerova M.
        • Subertova V.
        Frequency of nosocomial infections as revealed by a prevalence survey.
        J Hyg Epidemiol Microbiol Immunol. 1988; 32: 39-47
        • Maderova E.
        • Kertnerova V.
        • Cervenka J.
        • Pucekova C.
        Prevalence of nosocomial infections in selected hospitals.
        J Hyg Epidemiol Microbiol Immunol. 1987; 31: 365-374
        • Kampf G.
        • Gastmeier P.
        • Wischnewski N.
        • et al.
        Analysis of risk factors for nosocomial infections – results from the first national prevalence survey in Germany (NIDEP study, part 1).
        J Hosp Infect. 1997; 37: 103-112
        • Emmerson A.M.
        • Enstone J.E.
        • Griffith M.
        • Kelsey M.C.
        • Smyth E.T.M.
        The second national prevalence survey of infection in hospitals – overview of the results.
        J Hosp Infect. 1996; 32: 175-190
        • Scheel O.
        • Stormark M.
        National prevalence survey on hospital infections in Norway.
        J Hosp Infect. 1998; 41: 331-335
        • Vaqué J.
        • Rossello J.
        • Arribas J.L.
        • EPINE Working Group
        Prevalence of nosocomial infections in Spain: EPINE study 1990–1997.
        J Hosp Infect. 1999; 43: S105-S111
        • Gastmeier P.
        • Sohr D.
        • Rath A.
        • et al.
        Repeated prevalence investigations on nosocomial infections for continuous surveillance.
        J Hosp Infect. 2000; 45: 47-53
        • Pittet D.
        • Harbarth S.
        • Ruef C.
        • et al.
        Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland.
        Infect Control Hosp Epidemiol. 1999; 20: 37-42
        • Floret N.
        • Bailly P.
        • Bertrand X.
        • et al.
        Results from a four-year study on the prevalence of nosocomial infections in Franche-Comté: attempt to rank the risk of nosocomial infection.
        J Hosp Infect. 2006; 63: 393-398
        • French Prevalence Survey Study Group
        Prevalence of nosocomial infections in France: results of the nationwide survey in 1996.
        J Hosp Infect. 2000; 46: 186-193
        • Astagneau P.
        • Fleury L.
        • Leroy S.
        • et al.
        Cost of antimicrobial treatment for nosocomial infections based on a French prevalence survey.
        J Hosp Infect. 1999; 42: 303-312
        • Gravel D.
        • Matlow A.
        • Ofner M.
        • et al.
        A point prevalence survey of healthcare associated infections in pediatric populations in major Canadian acute-care hospitals.
        Am J Infect Control. 2007; 35: 157-162
      1. CDC. CDC definitions of nosocomial infections; 2004.

      2. Health Canada. Infections control guidelines for preventing infections associated with indwelling intravascular access devices. CCDR 1997; 2358.

      3. Health Canada. Infection control guidelines: routine practices and additional precautions for preventing the transmission of infection in health care. CCDR 1999. Report No. 25S4.

        • Johnson S.J.
        • Gerding D.N.
        Clostridium difficile.
        in: Mayhall C.G. Hospital epidemiology and infection control. 2nd ed. Lippincott, Williams & Wilkins, Philadelphia, PA1999: 467-476
        • Gastmeier P.
        • Brauer H.
        • Sohr D.
        • et al.
        Converting incidence and prevalence data of nosocomial infections: results from eight hospitals.
        Infect Control Hosp Epidemiol. 2001; 22: 31-34